Ramin Tehranchi

1.3k citations

29 papers · 742 indexed · h-index 15

Hematology top 2%
Genetics top 5%
Molecular Biology
Genetics
Endocrinology, Diabetes and Metabolism top 10%

Co-authors: Eva Hellström-Lindberg Bengt Fadeel Robert B. Howe Anna Porwit‐MacDonald Birger Christensson Boris Zhivotovsky Anders Rosholm Aida Inbal
Topics: Diabetes Management and Research (11 papers)Diabetes Treatment and Management (10 papers)Acute Myeloid Leukemia Research (7 papers)
Cited by: Hematology Genetics Endocrinology, Diabetes and Metabolism
Journals: Blood Diabetes Care Diabetes
Partner nations: United States Denmark Sweden

In The Last Decade

Ramin Tehranchi

27 papers receiving 721 citations

Peers

Countries citing papers authored by Ramin Tehranchi

Since Specialization

Citations

This map shows the geographic impact of Ramin Tehranchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramin Tehranchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramin Tehranchi more than expected).

Fields of papers citing papers by Ramin Tehranchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramin Tehranchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramin Tehranchi. The network helps show where Ramin Tehranchi may publish in the future.

Co-authorship network of co-authors of Ramin Tehranchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ramin Tehranchi. A scholar is included among the top collaborators of Ramin Tehranchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramin Tehranchi. Ramin Tehranchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study 2022 ·Current Therapeutic Research ·Ramin Tehranchi,Jonas Pettersson,Anita E. Melgaard,(unknown),(unknown),Stine Maarbjerg	0
2	Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial 2021 ·Diabetes Care ·Thomas R. Pieber,Ronnie Aronson,Ulrike Hövelmann,(unknown),Leona Plum‐Mörschel,Kim Knudsen,(unknown),Ramin Tehranchi	35
3	Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double‐blind trial 2021 ·Diabetes Obesity and Metabolism ·Timothy S. Bailey,(unknown),Leslie J. Klaff,(unknown),Anita E. Melgaard,Ramin Tehranchi	12
4	137-OR: Dasiglucagon Ready-to-Use Autoinjector Is More Reliably and Quickly Administered than Glucagon Emergency Kit (GEK) 2021 ·Diabetes ·(unknown),Jeannett Dimsits,Ramin Tehranchi,David M. Kendall,Timothy S. Bailey	2
5	356-P: Population Pharmacokinetic Modeling of Dasiglucagon in Subjects with Type 1 Diabetes Mellitus 2021 ·Diabetes ·Carsten Knudsen,(unknown),Stine Maarbjerg,Ramin Tehranchi,Paul M. Diderichsen,Han Witjes	1
6	Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial 2021 ·Pediatric Diabetes ·Tadej Battelino,Ramin Tehranchi,Timothy S. Bailey,Klemen Dovč,Anita E. Melgaard,(unknown),Stéphanie Woerner,Thekla von dem Berge,Linda A. DiMeglio,Thomas Danne	27
7	1053-P: Dasiglucagon Hypopal Autoinjector as a Fast and Effective Treatment for Severe Hypoglycemia: Results of a Phase 3 Trial 2020 ·Diabetes ·Timothy S. Bailey,(unknown),Leslie J. Klaff,(unknown),Anita E. Melgaard,Ramin Tehranchi	4
8	Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX 2016 ·Haemophilia ·Miguel A. Escobar,Ramin Tehranchi,Faraizah Abdul Karim,(unknown),Pratima Chowdary,T. Colberg,Paul Giangrande,Adam Giermasz,Maria Elisa Mancuso,M. Şerban,Woei Tsay,Johnny Mahlangu	21
9	Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4) 2016 ·Thrombosis Research ·Guy Young,Peter W. Collins,T. Colberg,Ampaiwan Chuansumrit,Hideji Hanabusa,Steven R. Lentz,Johnny Mahlangu,Evelien P. Mauser‐Bunschoten,Claude Négrier,Johannes Oldenburg,Türkan Patıroğlu,Elena Santagostino,Ramin Tehranchi,Marek Žák,Faraizah Abdul Karim	40
10	Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A‐subunit deficiency 2014 ·Journal of Thrombosis and Haemostasis ·Bryce A. Kerlin,B. Brand,Aida Inbal,Susan Halimeh,Diane J. Nugent,(unknown),Ramin Tehranchi	20
11	Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial 2014 ·Blood ·Guy Young,Peter W. Collins,Ramin Tehranchi,Ampaiwan Chuansumrit,Hideji Hanabusa,Steven R. Lentz,Johnny Mahlangu,Evelien P. Mauser‐Bunschoten,Claude Négrier,Johannes Oldenburg,Türkan Patıroğlu,Elena Santagostino,Marek Žák,F. Abdul Karim	3
12	Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients 2013 ·Haemophilia ·Michael D. Williams,Andrew Will,(unknown),Anders Rosholm,Ramin Tehranchi	15
13	Defining the Ideal Injection Techniques When Using 5-mm Needles in Children and Adults 2010 ·Diabetes Care ·Paul L. Hofman,(unknown),Teresa Pinto,(unknown),(unknown),(unknown),Paul Drury,Elizabeth Robinson,Ramin Tehranchi,Morten Donsmark,Wayne S. Cutfield	50
14	Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency 2010 ·Blood ·Aida Inbal,Johannes Oldenburg,Manuel Carção,Anders Rosholm,Ramin Tehranchi,Diane J. Nugent	2
15	Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro 2007 ·Cancer Chemotherapy and Pharmacology ·(unknown),Marina Vita,(unknown),Ramin Tehranchi,Christina Nilsson,Åke Sidén,Zuzana Hassan	15
16	Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes 2005 ·Blood ·Ramin Tehranchi	72
17	Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells 2004 ·Blood ·Göran Carlsson,Andrew A.G. Aprikyan,Ramin Tehranchi,David C. Dale,Anna Porwit,Eva Hellström-Lindberg,Jan Palmblad,Jan‐Inge Henter,Bengt Fadeel	71
18	Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors 2003 ·Blood ·Ramin Tehranchi,Bengt Fadeel,Ann‐Mari Forsblom,Birger Christensson,Jan Samuelsson,Boris Zhivotovsky,Eva Hellström‐Lindberg	97
19	The WHO classification of MDS does make a difference 2003 ·Blood ·Robert B. Howe,Anna Porwit‐MacDonald,(unknown),Ramin Tehranchi,Eva Hellström-Lindberg	103
20	Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts 2001 ·Leukemia ·(unknown),Ramin Tehranchi,(unknown),Bertrand Joseph,Birger Christensson,Bengt Fadeel,Boris Zhivotovsky,Eva Hellström‐Lindberg	29

About Ramin Tehranchi

Ramin Tehranchi is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 29 papers that have together received 742 indexed citations. Recurring topics across this work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (10 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (434 citations), Genetics (172 citations) and Endocrinology, Diabetes and Metabolism (119 citations). Ramin Tehranchi has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Eva Hellström-Lindberg, Bengt Fadeel, Robert B. Howe, Anna Porwit‐MacDonald, Birger Christensson, Boris Zhivotovsky, Anders Rosholm, Aida Inbal, Eva Hellström‐Lindberg and Johannes Oldenburg. Their work appears in journals such as Blood, Diabetes Care and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact